Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Evidence-Based Drug Therapy Update 2019 (Charleston)


Evidence-Based Drug Therapy Update
Hosted by the Medical University of South Carolina
 
Thursday, May 9 - Friday, May 10, 2019
 
Crowne Plaza Hotel
4831 Tanger Outlet Blvd
North Charleston, SC
 
 
BROCHURE AND LEARNING OBJECTIVES:  Click here to view.  Details for each session may also be found by expanding each session below.
 
REGISTRATION:
Online: Click here (to be taken directly to the registration page) or to learn more about this activity click here.
By Mail:  Mail registration form (found on page seven of the brochure - click here) with check made out to “Medical University of South Carolina” or credit card information to Elizabeth Gossen, Office of CME, Medical University of South Carolina, 96 Jonathan Lucas Street, HE221A, MSC 754, Charleston, SC, 29425
Telephone: (843) 876-1925 – Registration by credit card only
Fax: (843) 876-1931 – Registration by credit card only

Date: May 9, 2019 07:15 AM - May 10, 2019 05:00 PM

CE Hours

14.00

CE Units

1.400

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Medical University of South Carolina

Requirements for CE Credit

To claim credit for a session, participants must sign-in at and attend the entire session.  Participants must complete online evaluations (providing their correct NABP e-profile number and day/month of birth) in order to have credit reported to the NABP CPE Monitor.  Evaluations should be completed and credit claimed within 30 days of the live program to ensure transmission to the NABP CPE Monitor.  The NABP CPE Monitor will not accept any credit claimed and transmitted greater than 60 days from the date of the live program.
 
To verify your NABP e-Profile number and day/month of birth on record with NABP, please visit their website by selecting the link below.

 

 

 

 

 
At the completion of this activity, the participant will be able to:
  1. Identify appropriate contraception options for patients based on indications, side effects, route of administration, length of use and effectiveness.

Speaker(s)/Author(s)

Jennifer Bain, MD
Associate Professor, Clinical Services Director; Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-099-L01-P
Date: 05/09/19
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Contrast the pharmacologic features of methadone, buprenorphine, and naltrexone
  2. Describe the goals of an initial evaluation for patients with opioid use disorder
  3. Describe factors to consider in treatment planning to determine if Office-Based Opioid Treatment (OBOT) is appropriate for the patient
  4. Identify ways to train to get a buprenorphine waiver
  5. Identify where you can refer patients for MAT in your practice area

Speaker(s)/Author(s)

Sarah Bradford, MD
Assistant Professor, Department of Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-100-L01-P
Date: 05/09/19
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
    1. Identify when to prescribe weight loss medications
    2. Prescribe appropriate weight loss medications based on the individual patient
    3. Advise patients on diet plans based on current evidence
    4. Advise patients on exercise goals
    5. Incorporate other behavioral strategies into weight management plans

Speaker(s)/Author(s)

Kristen Hood Watson, MD
Assistant Dean for Resident Inclusion, Assistant Professor, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-101-L01-P
Date: 05/09/19
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Assess the need for added thyroid hormone lab studies in specific situations
  2. Recall existing data in treating subclinical hypothyroidism
  3. Discuss the question of using T3

Speaker(s)/Author(s)

Anita Ramsetty, MD, CCMS
Medical Director and Faculty Advisor, CARES Clinic, Assistant Professor, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-102-L01-P
Date: 05/09/19
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Compare benefits and risks of DOACs to standard of care anticoagulation in the treatment of cancerassociated thrombosis
  2. Identify patients with heparin-induced thrombocytopenia who may be candidates for DOACs
  3. Recognize patient-specific factors that may compromise safety or effectiveness of DOAC therapy

Speaker(s)/Author(s)

Nicole Bohm, PharmD, BCPS
Associate Professor, Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina

Activity Number

0062-9999-19-103-L01-P
Date: 05/09/19
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Identify patient-specific risk-enhancing factors that would indicate a patient??s need for statin therapy
  2. Incorporate the updated goals for LDL-C levels into current practice models
  3. Utilize non-statin pharmacotherapy options for certain patients
  4. Examine the supporting evidence responsible for the updated guidelines

Speaker(s)/Author(s)

Michael Corvino, PharmD, CDE
Adjunct Assistant Professor, CSU Physician Assistant Program; Clinical Pharmacist, Fetter Health Care Network; Diabetes Educator, Palmetto Pharmacist Network, Fetter Health Care Network

Activity Number

0062-9999-19-104-L01-P
Date: 05/09/19
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Articulate updates in dementia care and research
  2. Apply current recommendations and evidence in patients at risk of cognitive impairment

Speaker(s)/Author(s)

Russell Blackwelder, MD, MDiv
Assistant Professor, Director of Geriatric Education, MUSC Department of Family Medicine; Associate Medical Director, The Village at Summerville, MUSC

Activity Number

0062-9999-19-105-L01-P
Date: 05/09/19
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the participant will be able to:
  1. Describe the new IDSA guidelines regarding treatment of Clostridium difficile colitis
  2. Compare the antiviral treatment option for influenza
  3. Compare the treatment modalities for impetigo

Speaker(s)/Author(s)

Lisa Mims, MD, MS
Associate Program Director, Assistant Professor; Trident/MUSC Family Medicine Residency Program, Medical University of South Carolina

Activity Number

0062-9999-19-106-L01-P
Date: 05/10/19
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Compare and contrast the AHA/ACC/HFSA recommended pharmacologic therapies including target doses for patients with heart failure with reduced ejection fraction (HFrEF)
  2. Prescribe a guideline directed medical therapy to include specific medications and doses to a patient with HFrEF
  3. Recommend a target or goal blood pressure for a specific patient with hypertension based upon the current guidelines/data
  4. Recommend an evidence-based, cost effective antihypertensive medication regimen to a patient with hypertension

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, BCPS, FASHP, FAPhA
Professor of Clinical Pharmacy and Outcome Sciences, MUSC College of Pharmacy; Professor of Family Medicine, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-107-L01-P
Date: 05/10/19
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Interpret spirometry
  2. Adjust medication classes on the basis of both symptoms and exacerbation frequency
  3. Improve medication compliance in their patients by better understanding the definition of an exacerbation
  4. Determine when a CT scan is indicated for obstructive lung diseases

Speaker(s)/Author(s)

Charles Strange, MD
Professor, Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-108-L01-P
Date: 05/10/19
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Incorporate spirometry into the definition of asthma to improve the specificity of diagnosis
  2. Discuss with patients the removal of boxed warnings from some inhalers but not others regarding increased risk of asthma death
  3. Incorporate a checklist for patients who are poorly controlled on current asthma therapy
  4. Determine when to refer patients for biologic therapy for asthma

Speaker(s)/Author(s)

Charles Strange, MD
Professor, Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-109-L01-P
Date: 05/10/19
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Identify patients who need osteoporosis screening
  2. Determine how long patients should continue bisphosphonates or other treatments
  3. Reduce a patient's risk of fracture in both primary and secondary prevention

Speaker(s)/Author(s)

Scott Bragg, PharmD, BCPS
Assistant Professor, MUSC College of Pharmacy & Dept of Family Medicine

Activity Number

0062-9999-19-110-L01-P
Date: 05/10/19
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Discuss the history of cardiovascular outcomes trials (CVOT) for diabetes medications
  2. Compare the design and results of CVOT for DPP-4 inhibitors, thiazolidinediones, SGLT2 inhibitors, and GLP-1 receptor agonists
  3. Describe the role of CVOT in the 2019 ADA treatment algorithm

Speaker(s)/Author(s)

Morgan Adams, PharmD, BCACP
Assistant Professor, Dept of Family & Preventive Medicine, University of South Carolina School of Medicine

Activity Number

0062-9999-19-111-L01-P
Date: 05/10/19
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Discuss the FDA Warnings and label changes that relate to medication safety and how this information should be applied in the selection and monitoring of evidence-based pharmacotherapy to achieve better patient related outcome
  2. Describe the 2019 updated ACIP/CDC Immunization recommendations and new FDA approved vaccines
  3. Describe the current information concerning newly FDA approved medications (pharmacology, pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring and cost) in the selection of evidence-based pharmacotherapy

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, BCPS, FASHP, FAPhA
Professor of Clinical Pharmacy and Outcome Sciences, MUSC College of Pharmacy; Professor of Family Medicine, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-19-112-L01-P
Date: 05/10/19
Time: 04:00 PM - 05:00 PM

CE Hours

1.00